ASCO: Diet and Exercise in Cancer Prevention

Long-Term Follow-Up Spotlights Ongoing Positive Outcomes With Selpercatinib in RET Fusion–Positive Cancers

Promising EFS Noted Following Neoadjuvant Nivo/Chemo in Resectable NSCLC Following pCR

Phase 2 Alliance A059102 Trial Will Assess the Efficacy of Duvelisib/Azacitidine Plus CHOP/CHOEP for Peripheral T-Cell Lymphoma